To learn more about this report, request a free sample copy
The report is titled as ‘Disposable Autoinjectors Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the Disposable Autoinjectors market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. Disposable Autoinjectors market is expected to grow at a significant rate in the near future.
The global disposable autoinjectors market in 2020 is estimated for more than US$ 45.7 Bn and expected to reach at a value of US$ 172.3 Bn by 2028 with a significant CAGR of 18.1%.
In spite of numerous challenges, there has been significant progress in the healthcare industry with the considerable transformation of the services provided by the industry, which is expected to continue in the forecast period as well.
The disposable autoinjectors are also one of the advanced medical devices that are designed to infuse a dose of a particular medication to the patient. The autoinjectors are basically of two types that are reusable and disposable.
An autoinjector is a tiny, pen-shaped medical device that comprises an intravenous needle used for impregnating a specific dose of medication to patients, by injecting the syringe needle at the targeted spot of injection, and on a push of a button.
The disposable auto-injectors are preferred more over conventional injections and syringes as these are more convenient and easy-to-use medical devices for patients. Attributable to such factors, the global disposable autoinjectors market is projected to witness impressive growth in the given timeframe.
The capability to self-inject has been the core driver for the evolution of the autoinjectors across the world and presently, made them such a crucial element of the world of drug delivery medical devices for more than 25 years.
The disposable autoinjectors, generally, allows patients to use and infuse medications in emergency situations in an extremely easy and intuitive manner, which accelerates the demand of the medical device in the healthcare industry in a rapid manner.
Owing to which, the global disposable autoinjector market is projected to grow swiftly in the forthcoming years. In addition to that, the constantly rising prevalence of certain chronic diseases or certain allergies such as rheumatoid arthritis, diabetes, and multiple sclerosis are further positively fueling the demand of disposable autoinjectors across the world over the conventional injections with vials and syringes.
Owing to which, the global disposable autoinjectors market is expected to elevate briskly over the forecast period. Along with that, the disposable autoinjectors provides certain benefits to the patients such as ability to self-inject medications, easy-to-use, infusion of accurate dosage of medication, and even reduces the phobia of painful injections by providing a painless experience are few factors which further propels the demand of disposable autoinjectors among the population, hence propelling the growth of the global disposable autoinjectors market in the coming years.
Moreover, medical devices such as disposable autoinjectors allow patients to administer their own medication, which further gains traction for the medical device as it achieves the patient’s compliance across the world. Such factors also positively drive the growth of the global disposable autoinjectors market.
Apart from that, the constant technological advancements in the healthcare industry and its medical equipment as well as strong support from the government along with favorable reimbursements is also playing a major role in boosting the growth of the global disposable autoinjectors market in the near future.
Furthermore, the ever-increasing number of aging population and poor lifestyle of the population in the modern-day world is also contributing to the growing number of diseases among the population, thereby further stimulating the demand for disposable autoinjectors worldwide.
Therefore, the global disposable autoinjectors market is estimated to observe a significant growth in the forecast timeframe.
However, there are also a rising count of alternative options in the healthcare industry which may be estimated to confine the growth of the global disposable autoinjectors market in the near future.
The global disposable autoinjectors market is initially segmented on the basis of product type into disposable auto-injectors and reusable auto-injectors. Then, the reusable auto-injectors is further segmented into prefilled auto-injectors and empty auto-injectors. Further, the market is bifurcated on the basis of disease indication into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. Then, the market is further segmented on the basis of end-use into home care settings, hospitals & clinics, and ambulatory surgical centers. And at last, the global disposable autoinjectors market is divided on the basis of region into North America, Latin America, Middle East, Asia-Pacific, Africa and Europe.
The key participating players of global disposable autoinjectors market are Becton, Dickinson and Company, Ypsomed AG, SHL Medical AG, E3D Elcam Drug Delivery Devices, Haselmeier, Antares Pharma, Owen Mumford Ltd., AstraZeneca, among other prominent players.
The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Disposable Autoinjectors market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of Disposable Autoinjectors
Advantages of Disposable Autoinjectors
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
To learn more about this report, request a free sample copy
1. Global Disposable Autoinjectors Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Disposable Autoinjectors Market Overview
2.1. Introduction
2.1.1. Introduction
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Disposable Autoinjectors Market Snapshot
2.4. Global Disposable Autoinjectors Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Disposable Autoinjectors Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Disposable Autoinjectors Market, By Product Type
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Product Type
3.1.2. BPS Analysis, By Product Type
3.2. Market Revenue (US$Mn) Forecast, By Product Type
3.2.1. Disposable Auto-Injectors
3.2.2. Reusable Auto-Injectors
3.2.2.1. Prefilled Auto-Injectors
3.2.2.2. Empty Auto-Injectors
3.3. Global Disposable Autoinjectors Market Attractiveness Index, By Product Type
4. Global Disposable Autoinjectors Market, By Disease Indication
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Disease Indication
4.1.2. BPS Analysis, By Disease Indication
4.2. Market Revenue (US$Mn) Forecast, By Disease Indication
4.2.1. Rheumatoid Arthritis
4.2.2. Multiple Sclerosis
4.2.3. Diabetes
4.2.4. Anaphylaxis
4.2.5. Other Therapies
4.3. Global Disposable Autoinjectors Market Attractiveness Index, By Disease Indication
5. Global Disposable Autoinjectors Market, By End-Use
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By End-Use
5.1.2. BPS Analysis, By End-Use
5.2. Market Revenue (US$Mn) Forecast, By End-Use
5.2.1. Home Care Settings
5.2.2. Hospitals & Clinics
5.2.3. Ambulatory Surgical Centres
5.3. Global Disposable Autoinjectors Market Attractiveness Index, By End-Use
6. Global Disposable Autoinjectors Market, By Region
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Region
6.1.2. BPS Analysis, By Region
6.2. Market Revenue (US$Mn) Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East
6.2.6. Africa
6.3. Global Disposable Autoinjectors Market Attractiveness Index, By Region
7. North America Disposable Autoinjectors Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) Forecast, By Country
7.2.1. U.S. Disposable Autoinjectors Market
7.2.2. Canada Disposable Autoinjectors Market
7.3. North America Disposable Autoinjectors Market, By Product Type
7.3.1. Disposable Auto-Injectors
7.3.2. Reusable Auto-Injectors
7.3.2.1. Prefilled Auto-Injectors
7.3.2.2. Empty Auto-Injectors
7.4. North America Disposable Autoinjectors Market, By Disease Indication
7.4.1. Rheumatoid Arthritis
7.4.2. Multiple Sclerosis
7.4.3. Diabetes
7.4.4. Anaphylaxis
7.4.5. Other Therapies
7.5. North America Disposable Autoinjectors Market, By End-Use
7.5.1. Home Care Settings
7.5.2. Hospitals & Clinics
7.5.3. Ambulatory Surgical Centres
7.6. North America Disposable Autoinjectors Market Attractiveness Index
7.6.1. By Country
7.6.2. By Product Type
7.6.3. By Disease Indication
7.6.4. By End-Use
8. Latin America Disposable Autoinjectors Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market Revenue (US$Mn) Forecast, By Country
8.2.1. Brazil Disposable Autoinjectors Market
8.2.2. Mexico Disposable Autoinjectors Market
8.2.3. Argentina Disposable Autoinjectors Market
8.2.4. Rest of Latin America Disposable Autoinjectors Market
8.3. Latin America Disposable Autoinjectors Market, By Product Type
8.3.1. Disposable Auto-Injectors
8.3.2. Reusable Auto-Injectors
8.3.2.1. Prefilled Auto-Injectors
8.3.2.2. Empty Auto-Injectors
8.4. Latin America Disposable Autoinjectors Market, By Disease Indication
8.4.1. Rheumatoid Arthritis
8.4.2. Multiple Sclerosis
8.4.3. Diabetes
8.4.4. Anaphylaxis
8.4.5. Other Therapies
8.5. Latin America Disposable Autoinjectors Market, By End-Use
8.5.1. Home Care Settings
8.5.2. Hospitals & Clinics
8.5.3. Ambulatory Surgical Centres
8.6. Latin America Disposable Autoinjectors Market Attractiveness Index
8.6.1. By Country
8.6.2. By Product Type
8.6.3. By Disease Indication
8.6.4. By End-Use
9. Europe Disposable Autoinjectors Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market Revenue (US$Mn) Forecast, By Country
9.2.1. U.K. Disposable Autoinjectors Market
9.2.2. Germany Disposable Autoinjectors Market
9.2.3. Italy Disposable Autoinjectors Market
9.2.4. France Disposable Autoinjectors Market
9.2.5. Spain Disposable Autoinjectors Market
9.2.6. Russia Disposable Autoinjectors Market
9.2.7. Poland Disposable Autoinjectors Market
9.2.8. BENELUX Disposable Autoinjectors Market
9.2.9. NORDIC Disposable Autoinjectors Market
9.2.10. Rest of Europe Disposable Autoinjectors Market
9.3. Europe Disposable Autoinjectors Market, By Product Type
9.3.1. Disposable Auto-Injectors
9.3.2. Reusable Auto-Injectors
9.3.2.1. Prefilled Auto-Injectors
9.3.2.2. Empty Auto-Injectors
9.4. Europe Disposable Autoinjectors Market, By Disease Indication
9.4.1. Rheumatoid Arthritis
9.4.2. Multiple Sclerosis
9.4.3. Diabetes
9.4.4. Anaphylaxis
9.4.5. Other Therapies
9.5. Europe Disposable Autoinjectors Market, By End-Use
9.5.1. Home Care Settings
9.5.2. Hospitals & Clinics
9.5.3. Ambulatory Surgical Centres
9.6. Europe Disposable Autoinjectors Market Attractiveness Index
9.6.1. By Country
9.6.2. By Product Type
9.6.3. By Disease Indication
9.6.4. By End-Use
10. Asia Pacific Disposable Autoinjectors Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market Revenue (US$Mn) Forecast, By Country
10.2.1. China Disposable Autoinjectors Market
10.2.2. India Disposable Autoinjectors Market
10.2.3. Japan Disposable Autoinjectors Market
10.2.4. Australia And New Zealand Disposable Autoinjectors Market
10.2.5. South Korea Disposable Autoinjectors Market
10.2.6. ASEAN Disposable Autoinjectors Market
10.2.7. Rest of Asia Pacific Disposable Autoinjectors Market
10.3. Asia Pacific Disposable Autoinjectors Market, By Product Type
10.3.1. Disposable Auto-Injectors
10.3.2. Reusable Auto-Injectors
10.3.2.1. Prefilled Auto-Injectors
10.3.2.2. Empty Auto-Injectors
10.4. Asia Pacific Disposable Autoinjectors Market, By Disease Indication
10.4.1. Rheumatoid Arthritis
10.4.2. Multiple Sclerosis
10.4.3. Diabetes
10.4.4. Anaphylaxis
10.4.5. Other Therapies
10.5. Asia Pacific Disposable Autoinjectors Market, By End-Use
10.5.1. Home Care Settings
10.5.2. Hospitals & Clinics
10.5.3. Ambulatory Surgical Centres
10.6. Asia Pacific Disposable Autoinjectors Market Attractiveness Index
10.6.1. By Country
10.6.2. By Product Type
10.6.3. By Disease Indication
10.6.4. By End-Use
11. Middle East Disposable Autoinjectors Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market Revenue (US$Mn) Forecast, By Country
11.2.1. GCC Countries Disposable Autoinjectors Market
11.2.2. Israel Disposable Autoinjectors Market
11.2.3. Oman Disposable Autoinjectors Market
11.2.4. Rest of Middle East Disposable Autoinjectors Market
11.3. Middle East Disposable Autoinjectors Market, By Product Type
11.3.1. Disposable Auto-Injectors
11.3.2. Reusable Auto-Injectors
11.3.2.1. Prefilled Auto-Injectors
11.3.2.2. Empty Auto-Injectors
11.4. Middle East Disposable Autoinjectors Market, By Disease Indication
11.4.1. Rheumatoid Arthritis
11.4.2. Multiple Sclerosis
11.4.3. Diabetes
11.4.4. Anaphylaxis
11.4.5. Other Therapies
11.5. Middle East Disposable Autoinjectors Market, By End-Use
11.5.1. Home Care Settings
11.5.2. Hospitals & Clinics
11.5.3. Ambulatory Surgical Centres
11.6. Middle East Disposable Autoinjectors Market Attractiveness Index
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By Disease Indication
11.6.4. By End-Use
12. Africa Disposable Autoinjectors Market, By Region
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market Revenue (US$Mn) Forecast, By Country
12.2.1. South Africa Disposable Autoinjectors Market
12.2.2. Egypt Disposable Autoinjectors Market
12.2.3. North Africa Disposable Autoinjectors Market
12.2.4. Rest of Africa Disposable Autoinjectors Market
12.3. Africa Disposable Autoinjectors Market, By Product Type
12.3.1. Disposable Auto-Injectors
12.3.2. Reusable Auto-Injectors
12.3.2.1. Prefilled Auto-Injectors
12.3.2.2. Empty Auto-Injectors
12.4. Africa Disposable Autoinjectors Market, By Disease Indication
12.4.1. Rheumatoid Arthritis
12.4.2. Multiple Sclerosis
12.4.3. Diabetes
12.4.4. Anaphylaxis
12.4.5. Other Therapies
12.5. Africa Disposable Autoinjectors Market, By End-Use
12.5.1. Home Care Settings
12.5.2. Hospitals & Clinics
12.5.3. Ambulatory Surgical Centres
12.6. Africa Disposable Autoinjectors Market Attractiveness Index
12.6.1. By Country
12.6.2. By Product Type
12.6.3. By Disease Indication
12.6.4. By End-Use
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. Becton, Dickinson and Company
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. Ypsomed AG
14.3.3. SHL Medical AG
14.3.4. E3D Elcam Drug Delivery Devices
14.3.5. Haselmeier
14.3.6. Antares Pharma
14.3.7. Owen Mumford Ltd.
14.3.8. AstraZeneca
15. Acronyms
The global disposable autoinjectors market in 2020 is estimated for more than US$ 45.7 Bn and expected to reach at a value of US$ 172.3 Bn by 2028 with a significant CAGR of 18.1%.
The capability to self-inject has been the core driver for the evolution of the autoinjectors and constantly rising prevalence of certain chronic diseases or certain allergies such as rheumatoid arthritis, diabetes, and multiple sclerosis are the key factors driving the growth of market
The global disposable autoinjectors market is initially segmented on the basis of product type, disease indication, end-use, and region
The key participating players of global disposable autoinjectors market are Becton, Dickinson and Company, Ypsomed AG, SHL Medical AG, E3D Elcam Drug Delivery Devices, Haselmeier, Antares Pharma, Owen Mumford Ltd., AstraZeneca, among other prominent players.